Director/PDMR Shareholding

RNS Number : 3150U

GlaxoSmithKline PLC

14 October 2014

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors and Persons Discharging Managerial Responsibility (PDMR) on 14 October 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1404.00 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $45.63 per ADS following the notional re-investment of the dividend paid to shareholders on 2 October 2014.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	18,700.225
Dr M M Slaoui		5,761.611
Mr S Dingemans	7,854.435
Mr R G Connor	2,568.688
Mrs D P Connelly		2,395.995
Mr J Ford		309.896
Mr S A Hussain	6,371.575
Mr W C Louv		1,690.149
Mr D S Redfern	2,704.765
Ms C Thomas	3,732.993
Mr P C Thomson	1,820.901
Mr D E Troy		3,424.225
Dr P J T Vallance	7,777.092
Ms E Walmsley	4,520.938
Mrs V A Whyte	517.597

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

14 October 2014

 

END

 

 

RDSQZLFFZBFXFBL